| Active substance |
Naltrexone |
| Also known as |
LDN |
| Blood pressure |
No significant impact |
| Chemical name |
Naltrexone hydrochloride |
| Dosage (medical) |
Typically 3 to 4.5 mg per day |
| Dosage (sports) |
Not typically used in sports |
| Effects |
Modulates immune system, reduces inflammation, decreases feelings associated with chronic pain and autoimmune diseases |
| Formula |
C20H23NO4В·HCl |
| Half-life |
4 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not typically required for monitoring |
| Main action |
Reduces feelings of euphoria associated with opioid and alcohol use |
| Side effects |
Nausea, headache, dizziness, insomnia, anxiety |
| Storage conditions |
Store at room temperature, away from moisture and light |
| Strength |
1.5mg |
| Substance class |
Opioid antagonist |
| Trade name |
Revia, Depade |
| Use in sports |
Not generally used for enhancing physical performance |
| Water Retention |
No significant effect |
| Manufacturer |
Healing Pharma |
| Packing |
10 caps/blister |
